Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-04-15
1995-01-03
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 80, 514 81, 5142232, 544 10, 544 12, C07D28524, C07D41704/417/14, A61K 3154
Patent
active
053787048
ABSTRACT:
Novel compounds having the formula ##STR1## wherein R.sub.1, R.sub.2, X and Y are as defined herein. These compounds inhibit the action of angiotensin II and are useful, therefore, for example, as antihypertensive agents.
REFERENCES:
patent: 4870186 (1989-09-01), Aldrich
J. H. Freeman et al., "1,2,4-Benzothiadiazine Dioxides and 3,4-Dihydro-3,4-Dihydro-1,2,4-Benzothiadiazine Dioxides", J. Org. Chem 16, 815 (1951).
Chemical Abstract, 58, 4570f (1963).
K. S. Atwal et al., "Substituted 1,4-Dihydropyrimidines. 3. Synthesis of Selectively Functionalized 2-Hetero-1,4-dihydropyrimidines", J. Org. Chem 54, 25 (1989), pp. 5898-5907.
E. R. Squibb & Sons Inc.
Ford John M.
Park Ellen K.
LandOfFree
Non-peptidic angiotensin-II-receptor-antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-peptidic angiotensin-II-receptor-antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-peptidic angiotensin-II-receptor-antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2211639